Skip to main content

Guidelines for the design, conduct and reporting of human intervention studies to evaluate the health benefits of foods

  • Robert W. Welch (a1), Jean-Michel Antoine (a2), Jean-Louis Berta (a3), Achim Bub (a4), Jan de Vries (a5), Francisco Guarner (a6), Oliver Hasselwander (a7), Henk Hendriks (a8), Martin Jäkel (a9), Berthold V. Koletzko (a10), Chris C. Patterson (a11), Myriam Richelle (a12), Maria Skarp (a13), Stephan Theis (a14), Stéphane Vidry (a13) and Jayne V. Woodside (a11)...

There is substantial evidence to link what we eat to the reduction of the risk of major chronic diseases and/or the improvement of functions. Thus, it is important for public health agencies and the food industry to facilitate the consumption of foods with particular health benefits by providing consumer products and messages based on scientific evidence. Although fragmentary advice is available from a range of sources, there is a lack of comprehensive scientific guidelines for the design, conduct and reporting of human intervention studies to evaluate the health benefits of foods. Such guidelines are needed both to support nutrition science in general, and to facilitate the substantiation of health claims. In the present study, which presents the consensus view of an International Life Sciences Institute Europe Expert Group that included senior scientists from academia and industry, the term ‘foods’ refers to foods, dietary supplements and food constituents, but not to whole diets. The present study is based on an initial survey of published papers, which identified the range and strengths and weaknesses of current methodologies, and was finalised following exchanges between representatives from industry, academia and regulatory bodies. The major factors involved in the design, conduct and reporting of studies are identified, summarised in a checklist table that is based on the Consolidated Standards of Reporting Trials guidelines, and elaborated and discussed in the text.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Guidelines for the design, conduct and reporting of human intervention studies to evaluate the health benefits of foods
      Available formats
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Guidelines for the design, conduct and reporting of human intervention studies to evaluate the health benefits of foods
      Available formats
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Guidelines for the design, conduct and reporting of human intervention studies to evaluate the health benefits of foods
      Available formats
Corresponding author
Correspondence: ILSI Europe a.i.s.b.l., Avenue E. Mounier 83, Box 6 – 1200 Brussels, Belgium, fax: +32 2 762 00 44, email:
Hide All
1Brunner EJ, Rees K, Ward K, et al. (2007) Dietary advice for reducing cardiovascular risk. The Cochrane Database of Systematic Reviews, issue 4, CD002128.
2Van Horn L, McCoin M, Kris-Etherton PM, et al. (2008) The evidence for dietary prevention and treatment of cardiovascular disease. J Am Diet Assoc 108, 287331.
3World Cancer Research Fund (2007) Food, Nutrition, Physical Activity, and the Prevention of Cancer. A Global Perspective. (accessed October 2010).
4Asp N-G, Cummings JH, Mensink RP, et al. (2003) PASSCLAIM Phase one: preparing the way. Eur J Nutr 42, Suppl. 1, 1119.
5Asp N-G, Cummings JH, Howlett J, et al. (2004) PASSCLAIM Phase two: moving forward. Eur J Nutr 43, Suppl. 2, 1183.
6Aggett P, Antoine J-M, de Vries J, et al. (2010) Beyond PASSCLAIM – guidance to substantiate health claims on foods. Summary report of an ILSI Europe workshop held in December 2009 in Nice, France. (accessed August 2010).
7Moher D, Hopewell S, Schulz KF, et al. (2010) CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 340, c869.
8Sandstrom B (1995) Quality criteria in human experimental nutrition research. Eur J Clin Nutr 49, 315322.
9European Parliament and Council (2007) Corrigendum to regulation (EC) no. 1924/2006 of the European Parliament and of the council of 20th December 2006 on nutrition and health claims made on foods. OJ L 12, 318. (accessed October 2010).
10AbuMweis SS, Jew S & Jones PJ (2010) Optimizing clinical trial design for assessing the efficacy of functional foods. Nutr Rev 68, 485499.
11Klein MA, Nahin RL, Messina MJ, et al. (2010) Guidance from an NIH workshop on designing, implementing, and reporting clinical studies of soy interventions. J Nutr 140, 1192S1204S.
12Shane AL, Cabana MD & Vidry S (2010) Guide to designing, conducting, publishing and communicating results of clinical studies involving probiotic applications in human participants. Gut Microbes 1, 243253.
13Aggett PJ, Antoine J-M, Asp N-G, et al. (2005) PASSCLAIM process for the assessment of scientific support for claims on foods: consensus on criteria. Eur J Nutr 44, Suppl. 1, 130.
14EFSA (2007) Scientific and technical guidance for the preparation and presentation of the application for authorisation of a health claim. EFSA J 530, 144.
15European Commission (2008) Commission regulation (EC) No 353/2008 establishing implementing rules for applications for authorisation of health claims as provided for in article 15 of regulation (EC) No 1924/2006 of the European Parliament and of the council. OJ L 109, 1116. = OJ:L:2008:109:0011:0016:EN:PDF (accessed October 2010).
16Joint Health Claims Initiative (2000) Code of Practice on Claims on Foods. (accessed October 2010). .
17US FDA (2009) Guidance for Industry: Evidence-Based Review System for the Scientific Evaluation of Health Claims. (accessed October 2010).
18Health Canada, Bureau of Nutritional Sciences (2009) Guidance Document for Preparing a Submission for Food Health Claims. (accessed October 2010).
19Jones PJH, Asp N-G & Silva P (2008) Evidence for health claims on foods: how much is enough? Introduction and general remarks. J Nutr 138, S1192S1227.
20Codex Alimentarius Commission (2008) Proposed Draft Annex to the Codex Guidelines for the Use of Nutrition and Health Claims: Recommendations on the Scientific Substantiation of Health Claims. CRD 17. November 2008. (accessed October 2010).
21Food Standards Australia New Zealand (2008) Nutrition, Health and Related Claims – Final Assessment Report – Proposal P293. %20Health%20Claims%20FAR%20Attach%204 %20FINAL.pdf (accessed October 2010).
22Moher D & Tricco AC (2008) Issues related to the conduct of systematic reviews: a focus on the nutrition field. Am J Clin Nutr 88, 11911199.
23Pocock SJ (1983) Clinical Trials: A Practical Approach. Chichester: John Wiley & Sons.
24Piantadosi S (2005) Clinical Trials: A Methodological Perspective, 2nd ed.Hoboken, NJ: John Wiley & Sons.
25Machin D & Fayers P (2010) Randomized Clinical Trials: Design, Practice and Reporting. Chichester: Wiley-Blackwell.
26Friedman LM, Furberg CD & DeMets DL (2010) Fundamentals of Clinical Trials, 4th ed.New York: Springer.
27Peace KE & Chen D (2011) Clinical Trial Methodology. Boca Raton, FL: Chapman & Hall/CRC.
28UK Prospective Diabetes Study Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352, 837853.
29Mensink RP, Aro A, Den Hond E, et al. (2003) PASSCLAIM – diet-related cardiovascular disease. Eur J Nutr 42, Suppl. 1, 627.
30Prentice A, Bonjour JP, Branca F, et al. (2003) PASSCLAIM – bone health and osteoporosis. Eur J Nutr 42, Suppl. 1, 2849.
31Zhang X, Yap Y, Wei D, et al. (2008) Novel omics technologies in nutrition research. Biotechnol Adv 26, 169176.
32Winawer SJ, Zauber A, Ho MN, et al. (1993) Prevention of colorectal cancer by colonoscopic polypectomy. N Eng J Med 329, 19771981.
33Perez-Martinez P, Yiannakouris N, Lopez-Miranda J, et al. (2008) Postprandial triacylglycerol metabolism is modified by the presence of genetic variation at the perilipin (PLIN) locus in white populations. Am J Clin Nutr 87, 744752.
34Lee Y-M, Skurk T, Hennig M, et al. (2007) Effect of a milk drink supplemented with whey peptides on blood pressure in patients with mild hypertension. Eur J Nutr 46, 2127.
35Brink E, Coxam V, Robins S, et al. (2008) Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study. Am J Clin Nutr 87, 761770.
36World Medical Association (2008) Declaration of Helsinki, Ethical Principles for Medical Research Involving Human Subjects. (accessed October 2010).
37World Health Organisation, International Clinical Trials Registry Platform(2010) (accessed October 2010).
38International Committee of Medical Journal Editors(2010) (accessed October 2010).
39Krleza-Jeric K (2005) Clinical trial registration: the differing views of industry, the WHO, and the Ottawa Group. PLoS Med 2, e378.
40Bingham SA (1991) Limitations of the various methods for collecting dietary intake data. Ann Nutr Metab 35, 1727.
41European Medicines Agency (1995) Note for Guidance on Clinical Safety Data Management: Definitions and Standards for Expedited Reporting (CPMP/ICH/377/95). (accessed October 2010).
42International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (1996) Guideline for Good Clinical Practice E6(R1). (accessed October 2010).
43US Department of Health and Human Services, Food and Drug Administration (2010) Guidance for Industry and Investigators Safety Reporting Requirements for INDs and BA/BE Studies. (accessed 7 October 2010).
44Hills M & Armitage P (2004) The two-period cross-over clinical trial. Br J Clin Pharmacol 58, S703S716.
45Matthews JN, Altman DG, Campbell MJ, et al. (1990) Analysis of serial measurements in medical research. BMJ 300, 230235.
46Rowe SR, Alexander N, Clydesdale F, et al. (2009) Funding food science and nutrition research: financial conflicts and scientific integrity. Nutr Rev 67, 264272.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Altmetric attention score

Full text views

Total number of HTML views: 120
Total number of PDF views: 741 *
Loading metrics...

Abstract views

Total abstract views: 905 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 18th November 2017. This data will be updated every 24 hours.